Skip to main content

Pfizer Gaucher Personal Support (GPS)

Pfizer

OpenVerified·Apr 25, 2026

The Pfizer Gaucher Personal Support (GPS) program provides financial and insurance assistance for patients prescribed ELELYSO for Type 1 Gaucher disease. It offers a co-pay program for commercially insured patients (up to $15,000 annually) and a patient assistance program for uninsured or government-insured patients who meet financial qualifications. GPS also offers infusion support, including help researching transportation options to and from infusion sites.

Covers
financial assistance
Max award
$15,000
Enrollment cycle
rolling

Eligibility

Patients must be 4 years of age or older with a confirmed diagnosis of Type 1 Gaucher disease and be residents of the U.S. or Puerto Rico treated by U.S. physicians. Financial assistance is available for commercially insured patients via a co-pay program, while uninsured or government-insured patients may qualify for the Pfizer Patient Assistance Program.

Apply

Application goes directly to Pfizer. RxCopays does not receive compensation.

Go to application →

Status source

To enroll patients in the Elelyso Co-pay Program, please call Gaucher Personal Support at 1-855-ELELYSO

Rare-disease support beyond financial help

This grant covers a rare condition. For specialists, clinical trials, and patient communities, our sister site UniteRare.org has in-depth pages: